Tag: secukinumab

Pharma & Health

Cosentyx shows clinically meaningful symptom improvements in patients with painful skin condition in pivotal Phase III trials: Novartis

September 12, 2022

EMEAWIRE™ provides press release distribution services for businesses, organizations and other entities with the need to reach media outlets in Europe, Middle east and Africa (EMEA) Submit press release or contact us today.

Subscribe to Our Newsletter

No Result

View All Result

Tag: secukinumab

Cosentyx shows clinically meaningful symptom improvements in patients with painful skin condition in pivotal Phase III trials: Novartis

Categories

Subscribe to Our Newsletter

Browse by Category-